A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

NCT01331837 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3080

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Etanercept
DRUG: Tocilizumab

Sponsor

Hoffmann-La Roche